HBV-IN-25 - CAS 2161364-69-6

HBV-IN-25 is a novel chemical compound that acts as a potent HBV cccDNA reducer when administered orally. It exhibits significant anti-HBeAg potency and anti-HBV activity, with IC50 values of 0.58 μM and 1.15 μM, respectively. Moreover, HBV-IN-25 demonstrates favorable aqueous solubility (LYSA>452 μg/mL) and no cellular toxicity, making it a promising candidate for further investigation and development [1].

Others, HBV

Others, Microbiology/Virology

2161289

C18H14ClNO4

343.76

O=C1C=2C(OC=3C1=CC=CC3Cl)=CC(=CC2)N4C[C@H](C(O)=O)CC4

-20°C

Ice Packs

Small Compound